Investigating protein-ligand interactions with a mutant FKBP possessing a designed specificity pocket.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2000-02-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM9904396PMID 10737745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design and discovery of protein dimerizers.

  1999cited by this paper
• Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice

  1999cited by this paper
• Synthesis and activity of bivalent FKBP12 ligands for the regulated dimerization of proteins.

  1998cited by this paper
• A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src.

  1998cited by this paper
• Design of allele-specific inhibitors to probe protein kinase signaling.

  1998cited by this paper
• Engineering Src family protein kinases with unnatural nucleotide specificity.

  1998cited by this paper
• Redesigning small molecule-protein interfaces.

  1998cited by this paper
• Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity.

  1998cited by this paper
• Toward Antibody-directed Enzyme Prodrug Therapy with the T268G Mutant of Human Carboxypeptidase A1 and Novel in VivoStable Prodrugs of Methotrexate*

  1997cited by this paper
• Molecular Recognition of Proteinminus signLigand Complexes: Applications to Drug Design.

  1997cited by this paper
• A versatile synthetic dimerizer for the regulation of protein-protein interactions.

  1997cited by this paper
• Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates.

  1997cited by this paper
• A Single Amino Acid Difference between Cyclooxygenase-1 (COX-1) and −2 (COX-2) Reverses the Selectivity of COX-2 Specific Inhibitors*

  1996cited by this paper
• Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

  1996cited by this paper
• Controlling signal transduction with synthetic ligands.

  1993cited by this paper
• Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex.

  1992cited by this paper

• Sculpting Cell Fate: The Expanding Universe of Nondegradative Proximity‐Inducing Tools

  2026cites this paper
• Targeted Protein Acetylation Through Chemically Induced Proximity.

  2025cites this paper
• Dynamic activation of rAAV transgene expression by a small molecule that recruits endogenous transcriptional machinery

  2025cites this paper
• Comparative chemical genomics in Babesia species identifies the alkaline phosphatase PhoD as a determinant of antiparasitic resistance

  2024cites this paper
• Comparative chemical genomics in Babesia species identifies the alkaline phosphatase phoD as a novel determinant of resistance

  2023cites this paper
• Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53.

  2023cites this paper
• Manipulating PTPRD function with ectodomain antibodies

  2023cites this paper
• PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy

  2023cites this paper
• A heterobifunctional molecule system for targeted protein acetylation in cells.

  2023cites this paper
• Bioorthogonal Chemical Epigenetic Modifiers Enable Dose-Dependent CRISPR Targeted Gene Activation in Mammalian Cells.

  2022cites this paper
• Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors.

  2022cites this paper
• Targeted Protein Acetylation in Cells Using Heterobifunctional Molecules

  2021cites this paper
• Signaling by the integrated stress response kinase PKR is fine-tuned by dynamic clustering

  2021influential citation
• Applications of Targeted Protein Degradation in Drug Discovery

  2021cites this paper
• PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugs.

  2021cites this paper
• Establishment of chemically oligomerizable TAR DNA-binding protein-43 which mimics amyotrophic lateral sclerosis pathology in mammalian cells

  2021cites this paper
• Proteolysis-Targeting Chimeras Enhance T Cell Bispecific Antibody-Driven T Cell Activation and Effector Function through Increased MHC Class I Antigen Presentation in Cancer Cells

  2021cites this paper
• Co-option of Plasmodium falciparum PP1 for egress from host erythrocytes

  2020cites this paper
• Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface

  2020influential citation
• Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo.

  2020cites this paper
• Emerging technologies in protein interface engineering for biomedical applications.

  2019cites this paper
• Rapid Regulation of Human Mesenchymal Stem Cell Proliferation Using Inducible Caspase-9 Suicide Gene for Safe Cell-Based Therapy

  2019cites this paper
• Innate Immune Signaling Organelles Display Natural and Programmable Signaling Flexibility.

  2019cites this paper
• Synthesis of Shld Derivatives, Their Binding to the Destabilizing Domain, and Influence on Protein Accumulation in Transgenic Plants.

  2019cites this paper
• PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery

  2018cites this paper
• Chemogenetic Tools for Causal Cellular and Neuronal Biology.

  2018influential citation
• An Inexpensive and Scalable Synthesis of Shld.

  2018cites this paper
• FKBP Ligands—Where We Are and Where to Go?

  2018cites this paper
• Optimization of a “bump-and-hole” approach to allele-selective BET bromodomain inhibition† †Electronic supplementary information (ESI) available: Supplemental results (Fig. S1–S13 and Tables S1–S10). Crystallography data collection and refinement statistics. Experimental section. Detailed compound s

  2018cites this paper
• Knock off and on: a novel approach to autophagy modulation

  2017cites this paper
• Assessing Different E3 Ligases for Small Molecule Induced Protein Ubiquitination and Degradation.

  2017cites this paper
• Regulation of Amyloid Fibril Formation from Human Islet Amyloid Polypeptide by a Ligand Binding to the Fusion of FK506-binding Protein and the Insertion-in-Flap Domain

  2017cites this paper
• Niedermolekulare PROTACs: neue Wege zum Abbau von Proteinen

  2016cites this paper
• Growth signalobody selects functional intrabodies in the mammalian cytoplasm.

  2016cites this paper
• Small-Molecule PROTACS: New Approaches to Protein Degradation.

  2016cites this paper
• Quantifying protein dynamics in the ps–ns time regime by NMR relaxation

  2016cites this paper
• Quantifying protein dynamics in the ps–ns time regime by NMR relaxation

  2016cites this paper
• Ligand‐inducible dimeric antibody for selecting antibodies against a membrane protein based on mammalian cell proliferation

  2016cites this paper
• An analysis of FGF-regulated genes during Xenopus neural development

  2015cites this paper
• Coupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor Proteins*

  2015cites this paper
• Design and Characterization of Bifunctional Glucocorticoid Ligands Capable of Producing Novel Transcriptional Profiles.

  2015cites this paper
• Ligandengesteuerte Stabilisierung des Kaliumkanals Kir2.1 als neuer pharmakogenetischer Ansatz zur Inhibition von Neuronen

  2015cites this paper
• Conformational Dynamics in FKBP Domains: Relevance to Molecular Signaling and Drug Design.

  2015cites this paper
• Photocleavable Dimerizer for the Rapid Reversal of Molecular Trap Antagonists*

  2014cites this paper
• Detecting protein–protein interactions based on kinase-mediated growth induction of mammalian cells

  2014cites this paper
• Heterologous Expression of Equine CYP3A94 and Investigation of a Tunable System to Regulate Co-Expressed NADPH P450 Oxidoreductase Levels

  2014cites this paper
• Inducible protein dimerization: New tools and applications to understanding the mitotic checkpoint

  2014influential citation
• Steuerung der intrazellulären Proteinmenge durch niedermolekulare Modulatoren des Ubiquitin‐Proteasom‐Systems

  2014cites this paper
• Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system.

  2014cites this paper
• Structure-Affinity Properties of a High-Affinity Ligand of FKBP12 Studied by Molecular Simulations of a Binding Intermediate

  2014cites this paper
• Chemical-genetic induction of Malonyl-CoA decarboxylase in skeletal muscle

  2014cites this paper
• Accelerated Fibril Formation of α-Synuclein by an IF-Inserted F36V Mutant

  2013cites this paper
• Regulated expression systems for gene therapy

  2013cites this paper
• CHEMICAL GENETIC REGULATION OF MALONYL-COA DECARBOXYLASE IN SKELETAL MUSCLE INSULIN RESISTANCE

  2013cites this paper
• Targeted chemical-genetic regulation of protein stability in vivo.

  2012cites this paper
• Insertion of IF (insertion-in-flap) Domain into F36V to Provide Higher Activity of Peptidyl-propyl cis-trans Isomerase

  2012cites this paper
• On-chip bioorthogonal chemistry enables immobilization of in situ modified nanoparticles and small molecules for label-free monitoring of protein binding and reaction kinetics.

  2012cites this paper
• Recherche et caractérisation par dynamique moléculaire d'états intermédiaires pour la complexation entre la protéine FKBP12 et des ligands de haute affinité. (Study of building intermediate states between FKBP12 and high-affinity ligands by molecular dynamics simulations)

  2012influential citation
• We see the light: chemical-genetic protein regulation.

  2012cites this paper
• Role of polar and nonpolar residues at the active site for PPIase activity of FKBP22 from Shewanella sp. SIB1

  2012cites this paper
• Molecular Dynamics Simulations of a Binding Intermediate between FKBP12 and a High-Affinity Ligand.

  2011cites this paper
• Exploring a "Nature-Inspired" Strategy for Enhancing the Pharmacology of Small Molecules: Towards the Development of Next Generation Anti-Infectives.

  2011cites this paper
• Reducing versus basic properties of 1,2-diaryl-1,2-disodioethanes

  2011cites this paper
• Small molecule displacement of a cryptic degron causes conditional protein degradation

  2011cites this paper
• TagR promotes PpkA‐catalysed type VI secretion activation in Pseudomonas aeruginosa

  2009cites this paper
• Proteolysis Targeting Chimeric Molecules

  2009cites this paper
• Synthesis and analysis of stabilizing ligands for FKBP-derived destabilizing domains.

  2008cites this paper
• Efficient one-cycle affinity selection of binding proteins or peptides specific for a small-molecule using a T7 phage display pool.

  2008cites this paper
• Heterogeneity and Pliability of Tumor-educated Macrophages

  2008cites this paper
• Peptidyl-prolyl cis/trans Isomerases

  2008cites this paper
• Computational Approach for the Design of AP1867 Analogs: Aiming at New Synthetic Routes for Potential Immunosuppressant Agents

  2007cites this paper
• Chemical control over protein-protein interactions: beyond inhibitors.

  2007cites this paper
• A Directed Approach for Engineering Conditional Protein Stability Using Biologically Silent Small Molecules*

  2007cites this paper
• Aggregation of cellular prion protein is initiated by proximity‐induced dimerization

  2007cites this paper
• Establishment of a Cell Model Based on FKBP12 Dimerization for Screening of FK506-like Neurotrophic Small Molecular Compounds

  2006cites this paper
• A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.

  2006cites this paper
• Congenital amegakaryocytic thrombocytopenia in three siblings: molecular analysis of atypical clinical presentation.

  2005cites this paper
• Chemical Approaches to Controlling Intracellular Protein Degradation

  2005cites this paper
• Insights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases.

  2004cites this paper
• Structural Basis for Endosomal Targeting by FYVE Domains*

  2004cites this paper
• Chemical genetic control of protein levels: selective in vivo targeted degradation.

  2004cites this paper
• Correlation between ligand-receptor affinity and the transcription readout in a yeast three-hybrid system.

  2004cites this paper
• Protein‐protein interactions as a target for drugs in proteomics

  2003cites this paper
• Regulation of gene expression by synthetic dimerizers with novel specificity.

  2003cites this paper
• Optimizing immunity against BCR-ABL positive leukemia

  2003cites this paper
• Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity--targets--functions.

  2003cites this paper
• Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells.

  2002cites this paper
• Immunological consequences of apoptosis in a tumor system

  2002cites this paper
• 703 Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary

  2002cites this paper
• Synthesis of calcineurin-resistant derivatives of FK506 and selection of compensatory receptors.

  2002cites this paper
• Inducible dimerization of FGFR1

  2002cites this paper
• Protein–protein interactions: mechanisms and modification by drugs

  2002cites this paper
• The estrogen receptor: a structure-based approach to the design of new specific hormone-receptor combinations.

  2001cites this paper
• Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity.

  2001cites this paper
• The Impact of Mammalian Gene Regulation Concepts on Functional Genomic Research, Metabolic Engineering, and Advanced Gene Therapies

  2001cites this paper
• A ligand-reversible dimerization system for controlling protein-protein interactions.

  2000cites this paper